Marketing-authorisation holder Β· Canada
Grey Wolf Animal Health Inc
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATAJECT5 mg / ml Β· Solution | Atipamezole | Canada | Marketed | 2021 |
| FATAL-PLUS390 mg / ml Β· Solution | Pentobarbital | Canada | Marketed | 2025 |
| SEDAJECT0.5 mg / ml Β· Solution | Dexmedetomidine | Canada | Marketed | 2021 |
| INCONTEROL1 mg Β· Tablet | Diethylstilbestrol | Canada | Cancelled | |
| PROPYLENE GLYCOL, USP100 % / v/v Β· Liquid | Propylene glycol | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 5 | 3 | 2 | CompaniesAll medicines |



